Wellumio Expands into California to Impact Stroke Detection
Slice of Healthcare Team
Jan 09, 2025
Key Highlights
- Wellumio launches California subsidiary to expand its global presence and conduct U.S.-based clinical trials.
- Axana device offers rapid, portable stroke detection using Pulsed Gradient Free Mapping (PGFM).
- FDA pre-submission meetings complete, moving toward regulatory filings.
- Leadership expansion with Sia Moussavi, Ziad Rouag, and Daniel Weyers joining the team.
Source: PR Newswire
Notable Quote
“ We've designed a novel device that is highly portable and significantly faster than traditional MRIs, making it ideal for quick assessments in emergency situations. ”
Shieak Tzeng, CEO at Wellumio
